Skip to content
Friday, November 13, 2026
Discover Brit Club Market, the premier online marketplace i…

Patients Discontinuing Slimming Medications Put On Pounds Far More Rapidly Than Those on Conventional Diets

Image of medical syringe and scale
Weight management involves ongoing approaches.

Fresh analysis indicates that people who discontinue popular weight-loss injections like semaglutide or tirzepatide may regain reduced body mass much more quickly than those who halt traditional lifestyle regimens.

Findings released in a major health publication points out that while overweight people frequently drop about a fifth of their total mass while undergoing treatment, the mass comes back at an average rate of nearly a kilo each month upon discontinuation.

"Users purchasing these medications should be aware of the risk of fast weight regain when the medication concludes," warns researcher Dr. Susan Jebb.

That rate of regain means a reversion to original mass in about a year and a half.

Analyzing Approaches

The analysis, which examined dozens of trials involving over 9,000 of participants, contrasted the effects of these new drugs with conventional dieting.

Scientists emphasize that people who lose weight through diet and exercise generally see a more gradual creep back—around 0.1 kg a month—post-intervention.

The Reason for the Fast Rebound

Nutrition scientists suggest the mechanism of the injections accounts for the accelerated rebound.

The injections copy a natural hormone called GLP-1, which moderates appetite.

"Artificially providing GLP-1 concentrations several times higher than the body's typical production may cause the body to produce less of its endogenous hormone, and could lessen responsiveness to its effects," said Dr. Adam Collins, a dietetics researcher.

"Stopping of this GLP-1 'fix' leads to hunger is no longer kept in check, making excessive eating far more likely."

A Lifelong Issue?

The NHS suggest the jabs for individuals with weight-linked medical conditions, accompanied by prescribed diet and exercise modifications.

Professionals argue that, given the high risk of weight regain, the treatment might need to be long-term.

This view is echoed by pharmaceutical companies, who note that the findings "underscore the chronic character of excess weight," comparing it to managing conditions like high blood pressure.

User Accounts

People who have come off the jabs explain a sudden return of hunger.

"It felt as if a trigger flipping and you're instantly starving," described a patient.

The struggle is exacerbated if users have not established permanent dietary or behavioural modifications during therapy.

Significant Use

Survey data suggest that a significant number of adults in the UK have used these injections in the last 12 months, with desire remaining high.

  • Use is more common among females compared to males.
  • The middle-aged demographic shows the greatest level of interest.
  • A large proportion obtain the medications through private prescriptions rather than the NHS.

Finally, researchers caution that while GLP-1 drugs are powerful tools for weight loss, they are not a permanent fix and long-term success relies on ongoing behavioural support.

EF
About the author

Eric Figueroa

Eleanor Vance is a seasoned e-commerce analyst and content strategist with over a decade of experience in digital marketplaces.

Brit Club Market

Type to search articles.